CardioVascular and Interventional Radiology

, Volume 36, Issue 4, pp 904–912

The Changing Face of Vascular Interventional Radiology: The Future Role of Pharmacotherapies and Molecular Imaging

Review/State of the Art

DOI: 10.1007/s00270-013-0621-3

Cite this article as:
Tapping, C.R. & Bratby, M.J. Cardiovasc Intervent Radiol (2013) 36: 904. doi:10.1007/s00270-013-0621-3
  • 2k Downloads

Abstract

Interventional radiology has had to evolve constantly because there is the ever-present competition and threat from other specialties within medicine, surgery, and research. The development of new technologies, techniques, and therapies is vital to broaden the horizon of interventional radiology and to ensure its continued success in the future. In part, this change will be due to improved chronic disease prevention altering what we treat and in whom. The most important of these strategies are the therapeutic use of statins, Beta-blockers, angiotensin-converting enzyme inhibitors, and substances that interfere with mast cell degeneration. Molecular imaging and therapeutic strategies will move away from conventional techniques and nano and microparticle molecular technology, tissue factor imaging, gene therapy, endothelial progenitor cells, and photodynamic therapy will become an important part of interventional radiology of the future. This review looks at these new and exciting technologies.

Keywords

Clinical practiceExperimental IRImagingChemoembolizationCombined treatmentsDiagnosticEmbolizationLaser treatmentUltrasound

Copyright information

© Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2013

Authors and Affiliations

  1. 1.Department of RadiologyOxford University Hospitals, John Radcliffe HospitalHeadington, OxfordUK
  2. 2.Department of RadiologyOxford University Hospitals, Churchill HospitalHeadingtonUK